Experts at Royal Brompton and Harefield hospitals care for patients with a wide range of complex cardiac conditions, both congenital (present at birth), inherited and acquired later in life.
The Trust is the world’s leading centre for congenital heart disease research and a national and international training centre for cardiologists, cardiothoracic surgeons and other clinicians, treating patients from birth through to adulthood. The adult congenital heart disease (ACHD) unit at Royal Brompton is one of the largest specialist centres in the world.
We have one of the fastest primary angioplasty services in the UK at Harefield’s Heart Attack Centre, and offer the largest implantable cardiac device (ICD) service in the UK (including pacemakers and debrillators).
Our transcatheter aortic valve implantation (TAVI) service enjoys an international reputation. TAVI is a non-surgical alternative to open-heart surgery for patients with a narrowed aortic valve and is carried out in the Trust’s ground-breaking hybrid theatre.
Our pulmonary hypertension service is one of only seven designated in the country that form the National Pulmonary Hypertension Service (NPHS) for England.